CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt (bibtex)

by Berres, Marie-Luise, Asmacher, Sonja, Lehmann, Jennifer, Jansen, Christian, Görtzen, Jan, Klein, Sabine, Meyer, Carsten, Strunk, Holger M., Fimmers, Rolf, Tacke, Frank, Strassburg, Christian P., Trautwein, Christian, Sauerbruch, Tilman, Wasmuth, Hermann Elard and Trebicka, Jonel

Reference:

M. Berres, S. Asmacher, J. Lehmann, C. Jansen, J. Görtzen, S. Klein, C. Meyer, H. M. Strunk, R. Fimmers, F. Tacke, C. P. Strassburg, C. Trautwein, T. Sauerbruch, H. E. Wasmuth, J. Trebicka, "CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt", J. Hepatol., vol. 62, no. 2, pp. 332–339.

Bibtex Entry:

@Article{Berres:480482,
  Author          = {Berres, Marie-Luise and Asmacher, Sonja and Lehmann,
                    Jennifer and Jansen, Christian and Görtzen, Jan and
                    Klein, Sabine and Meyer, Carsten and Strunk, Holger M.
                    and Fimmers, Rolf and Tacke, Frank and Strassburg,
                    Christian P. and Trautwein, Christian and Sauerbruch,
                    Tilman and Wasmuth, Hermann Elard and Trebicka, Jonel},
  Title           = {{CXCL9} is a prognostic marker in patients with liver
                    cirrhosis receiving transjugular intrahepatic
                    portosystemic shunt},
  JournalTitle    = {J. Hepatol.},
  Date            = {2015},
  DOI             = {10.1016/j.jhep.2014.09.032},
  Number          = {2},
  Pages           = {332--339},
  Volume          = {62}
}